Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and Corynebacterium Infections

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Corynebacterium Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blobner, M; Jeevendra Martyn, JA; Kem, WR; Khan, MAS; Lewald, H; Nagashima, M; Sasakawa, T; Schaller, SJ; Schlegel, J; Schneider, G; Schönfelder, M; Schulz, F1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Corynebacterium Infections

ArticleYear
GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy.
    Pflugers Archiv : European journal of physiology, 2018, Volume: 470, Issue:11

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Body Weight; Corynebacterium Infections; Immobilization; Male; Methemoglobin; Muscle, Skeletal; Muscular Atrophy; Nicotinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome

2018